Evaluating treatments and outcomes for Canadians with cancer: this research provides insight into how the quality of cancer care can be improved, and whether patients in Canada are achieving the best possible outcomes. 

Queen's researcher Michael Brundage discusses his research on quality of life which he undertakes as part of the Canadian Cancer Trials Group and the Queen's Cancer Research Institute.

Queen's cancer research Jim Biagi will lead a promising international trial that could introduce a new chemotherapy regimen to improve the survival rate of patients undergoing surgery for gastrointestinal and gynaecological cancers.